Page last updated: 2024-11-05

malonamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Malonamide is a dicarboxylic acid amide with the formula CH2(CONH2)2. It is a white, crystalline solid that is soluble in water. Malonamide is a versatile building block in organic synthesis and has been investigated for its potential applications in a range of fields, including:

- **Synthesis:** Malonamide can be synthesized through various methods, including the reaction of malonic acid with ammonia. Its structure allows for the formation of diverse derivatives via reactions such as alkylation, acylation, and condensation.
- **Bioactivity:** Malonamide derivatives have shown biological activity, including anti-inflammatory, antimicrobial, and anticancer properties. For instance, certain malonamide derivatives have exhibited inhibitory activity against enzymes involved in inflammation and cancer.
- **Materials Science:** Malonamide derivatives can form supramolecular structures, which have potential applications in fields like nanotechnology and materials science. They have been investigated for their ability to self-assemble into nanostructures and exhibit unique optical and electronic properties.
- **Research Focus:** Malonamide and its derivatives are a subject of ongoing research due to their potential applications in various fields. Researchers are investigating their properties, synthesizing new derivatives, and exploring their therapeutic and material science applications.'

malonamide : A dicarboxylic acid diamide that is malonic acid in which both carboxy groups have been replaced by carbamoyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7911
CHEBI ID48537
SCHEMBL ID292267
SCHEMBL ID8519333
MeSH IDM0052044

Synonyms (42)

Synonym
F1918-0086
propanediamide
malondiamide
108-13-4
malonodiamide
malonic acid diamide
carboxamidoacetamide
wln: zv1vz
nsc2134
nsc-2134
malonyldiamide
malonamide
nsc 2134
ai3-24284
malonic diamide
einecs 203-553-8
malonamide, 97%
B7ADF368-69FC-4139-A4AF-9F37A8B615B4
AKOS000118771
M0027
propanediamide;malonodiamide
A801813
unii-qvq8cng255
qvq8cng255 ,
methane-1,1-dicarboxamide
FT-0628124
SCHEMBL292267
malon diamide
SCHEMBL8519333
DTXSID1040116
J-002064
mfcd00008034
CHEBI:48537
CS-W011312
malonamid
AS-14797
EN300-19422
STL199178
SY018470
D77721
Q27287520
Z104473780
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dicarboxylic acid diamide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (20.00)18.7374
1990's2 (4.44)18.2507
2000's12 (26.67)29.6817
2010's20 (44.44)24.3611
2020's2 (4.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.76 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.13%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]